BOSTON , Aug. 26, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences and healthcare supply chain, proudly announces it has become the first and only solution provider to secure all 16 GS1 US Conformance Trustmarks for EPCIS file support. These trustmarks certify that a company's systems meet stringent criteria for accurately and securely exchanging traceability data, ensuring compliance with the Drug Supply Chain Security Act (DSCSA) requirements for tracking and tracing prescription drugs through the supply chain.
This landmark achievement sets a new industry standard in the U.S. pharmaceutical supply chain's efforts to meet the DSCSA requirements.
This comprehensive certification encompasses 7 trustmarks supporting manufacturers to downstream trading partners and 9 trustmarks aiding wholesalers to dispensers. The attainment of all available trustmarks underlines TraceLink's commitment to excellence and compliance in the pharmaceutical industry, providing assurance that the EPCIS messages sent on behalf of our clients—manufacturers, wholesalers, and dispensers—are in full compliance with the application standards set by GS1 US, the publisher of the GS1 US Implementation Guideline: Applying GS1 Standards for DSCSA and Traceability, Release 1.2 .
This ensures that TraceLink customers can seamlessly track and trace their products, reducing operational risks, enhancing supply chain transparency, .